Rachel Joyce Kearns
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rachel Joyce Kearns has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
- Alan James Robert Macfarlane
School of Health and Wellbeing, University of Glasgow, UK
12 shared publications Martin Shaw
Department of Clinical Physics and Bioengineering, NHS Greater Glasgow and Clyde, Glasgow, UK
8 shared publications- Scott McGill Nelson
School of Medicine, University of Glasgow, Glasgow, UK
5 shared publications - Debbie A. Lawlor
MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
4 shared publications J. Kinsella
Glasgow Royal Infirmary, Glasgow, UK
4 shared publications- James Simeon Bowness
Department of Anaesthesia, University College London Hospitals NHS Foundation Trust, London, UK
4 shared publications
Latest Publications
- Open Access
Epidural analgesia in labour and neonatal and childhood outcomes: national population based cohort study
Objectives: To examine whether epidural analgesia in labour is associated with neonatal neurological morbidity, other neonatal morbidity, neonatal sepsis, low Apgar score, neonatal mortality, and childhood cerebral palsy. Design: National population based cohort study. Setting: All NHS hospitals in Scotland, using Scottish NHS administrative linked data. Participants: 495 695 women in labour with a singleton pregnancy between 24+0 and 42+6 weeks’ gestation delivering vaginally or via unplanned caesarean birth between 1 January 2007 and 31 December 2019. Main outcome measures: The primary outcome was neonatal neurological morbidity defined using ICD-10 codes as one or more of hypoxic ischaemic encephalopathy, neonatal seizures, intraventricular haemorrhage, intraventricular infarction, periventricular leukomalacia, meningitis, encephalitis, kernicterus, hypotonia, birth asphyxia, or other cerebral diagnosis occurring within 28 days of birth. Secondary outcomes were other neonatal morbidity (one or more of acidosis at birth (cord artery pH <7.10), traumatic birth injury, brachial plexus injury, necrotising enterocolitis, respiratory distress syndrome, respiratory failure, pneumothorax, hypoglycaemia, or hypothermia), neonatal sepsis, Apgar score <4 at five minutes following birth, neonatal mortality, and cerebral palsy diagnosed at any point during childhood. Results: Of the 495 695 women, 114 897 (23.2%) had epidural analgesia in labour. Neonatal neurological morbidity occurred in 434 babies (0.9 per 1000 births, 95% confidence interval (CI) 0.8 to 1.0). No association was found between epidural analgesia in labour and neonatal neurological morbidity (adjusted relative risk 0.87, 95% CI 0.68 to 1.12), other severe neonatal morbidity (1.17, 0.90 to 1.51), neonatal sepsis (1.11, 0.90 to 1.37), Apgar score <4 at five minutes (0.97, 0.87 to 1.09), neonatal mortality at 28 days (0.81, 0.62 to 1.06), or cerebral palsy in childhood (0.80, 0.60 to 1.06). Findings were consistent across subgroups including women considered to have high risk pregnancies, preterm births, and across different modes of birth. Conclusion: Epidural analgesia during labour was not associated with clinically significant risks of harm to newborn babies or children, including risks of neonatal morbidity, death, or cerebral palsy. These findings have important policy implications, and support widening availability and equitable access to epidural analgesia as a safe component of intrapartum care.
Open AccessEpidural analgesia in labour and neonatal and childhood outcomes: national population based cohort study
Objectives: To examine whether epidural analgesia in labour is associated with neonatal neurological morbidity, other neonatal morbidity, neonatal sepsis, low Apgar score, neonatal mortality, and childhood cerebral palsy. Design: National population based cohort study. Setting: All NHS hospitals in Scotland, using Scottish NHS administrative linked data. Participants: 495 695 women in labour with a singleton pregnancy between 24+0 and 42+6 weeks’ gestation delivering vaginally or via unplanned caesarean birth between 1 January 2007 and 31 December 2019. Main outcome measures: The primary outcome was neonatal neurological morbidity defined using ICD-10 codes as one or more of hypoxic ischaemic encephalopathy, neonatal seizures, intraventricular haemorrhage, intraventricular infarction, periventricular leukomalacia, meningitis, encephalitis, kernicterus, hypotonia, birth asphyxia, or other cerebral diagnosis occurring within 28 days of birth. Secondary outcomes were other neonatal morbidity (one or more of acidosis at birth (cord artery pH <7.10), traumatic birth injury, brachial plexus injury, necrotising enterocolitis, respiratory distress syndrome, respiratory failure, pneumothorax, hypoglycaemia, or hypothermia), neonatal sepsis, Apgar score <4 at five minutes following birth, neonatal mortality, and cerebral palsy diagnosed at any point during childhood. Results: Of the 495 695 women, 114 897 (23.2%) had epidural analgesia in labour. Neonatal neurological morbidity occurred in 434 babies (0.9 per 1000 births, 95% confidence interval (CI) 0.8 to 1.0). No association was found between epidural analgesia in labour and neonatal neurological morbidity (adjusted relative risk 0.87, 95% CI 0.68 to 1.12), other severe neonatal morbidity (1.17, 0.90 to 1.51), neonatal sepsis (1.11, 0.90 to 1.37), Apgar score <4 at five minutes (0.97, 0.87 to 1.09), neonatal mortality at 28 days (0.81, 0.62 to 1.06), or cerebral palsy in childhood (0.80, 0.60 to 1.06). Findings were consistent across subgroups including women considered to have high risk pregnancies, preterm births, and across different modes of birth. Conclusion: Epidural analgesia during labour was not associated with clinically significant risks of harm to newborn babies or children, including risks of neonatal morbidity, death, or cerebral palsy. These findings have important policy implications, and support widening availability and equitable access to epidural analgesia as a safe component of intrapartum care.
- Open Access
- 9 July 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (3) , 838-848
Regional anaesthesia and chronic postsurgical pain: a systematic review and network meta-analysis
- 9 July 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (3) , 838-848
Open AccessRegional anaesthesia and chronic postsurgical pain: a systematic review and network meta-analysis
- Open Access
- 24 March 2026
- Published by Elsevier in SSRN Electronic Journal
Anaesthesia Choice for Creation of Arteriovenous Fistula (ACCess) Study: A Randomised Trial Comparing Regional Versus Local Anaesthesia in Arteriovenous Dialysis Fistula
Background: Haemodialysis (HD) is the most common form of kidney replacement therapy in patients with established renal failure worldwide. Vascular access is the key modifiable risk factor affecting morbidity and mortality for patients on HD. An arteriovenous fistula (AVF) is the optimal vascular access for HD. Initial data suggest that anaesthetic technique may affect AVF outcomes, but no definite evidence confirms this. Methods: An observer-blinded randomised controlled trial was performed at 20 UK centres. Adults undergoing radio-/brachio-cephalic fistula creation were randomly assigned 1:1 to receive either regional anaesthesia (RA) (brachial plexus block with 0.5% L-bupivacaine and 1% lidocaine with adrenaline) or local anaesthesia (LA) (0.5% L-bupivacaine and 1% lidocaine). The primary end point was unassisted functional patency at 12 months. Cost-effectiveness analysis was also performed. Findings: 571 patients were randomised. Unassisted functional AVF patency at 3 and 12 months was 60.3% (n=479) (RA 60.7% vs LA 60.0%, p=0.65) and 56.7% (n=420) (RA 58.9% vs LA 54.5%, p=0.30 respectively. Unassisted functional AVF patency in brachiocephalic fistulae was greater in the RA group compared to LA (66.3% vs 53.4%, p=0.04). There was no significant interaction in subgroups of vessel size (p=0.2). Mortality at 1-year was 10.1% (n=57) (RA 8.5% vs LA 11.7%, p=0.20). RA saved £1,139 per patient compared to LA (95% CI: -£1,255 to -£1,021; p<0.001), driven by fewer dialysis costs and infections. Interpretation: Both anaesthetic techniques are safe and efficacious. There was no clinical difference in fistula outcomes between the two groups. Regional anaesthesia proved cost-effective over a one-year time horizon when dialysis costs were excluded. Either technique continues to be appropriate for AVF creation.
- 24 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAnaesthesia Choice for Creation of Arteriovenous Fistula (ACCess) Study: A Randomised Trial Comparing Regional Versus Local Anaesthesia in Arteriovenous Dialysis Fistula
Background: Haemodialysis (HD) is the most common form of kidney replacement therapy in patients with established renal failure worldwide. Vascular access is the key modifiable risk factor affecting morbidity and mortality for patients on HD. An arteriovenous fistula (AVF) is the optimal vascular access for HD. Initial data suggest that anaesthetic technique may affect AVF outcomes, but no definite evidence confirms this. Methods: An observer-blinded randomised controlled trial was performed at 20 UK centres. Adults undergoing radio-/brachio-cephalic fistula creation were randomly assigned 1:1 to receive either regional anaesthesia (RA) (brachial plexus block with 0.5% L-bupivacaine and 1% lidocaine with adrenaline) or local anaesthesia (LA) (0.5% L-bupivacaine and 1% lidocaine). The primary end point was unassisted functional patency at 12 months. Cost-effectiveness analysis was also performed. Findings: 571 patients were randomised. Unassisted functional AVF patency at 3 and 12 months was 60.3% (n=479) (RA 60.7% vs LA 60.0%, p=0.65) and 56.7% (n=420) (RA 58.9% vs LA 54.5%, p=0.30 respectively. Unassisted functional AVF patency in brachiocephalic fistulae was greater in the RA group compared to LA (66.3% vs 53.4%, p=0.04). There was no significant interaction in subgroups of vessel size (p=0.2). Mortality at 1-year was 10.1% (n=57) (RA 8.5% vs LA 11.7%, p=0.20). RA saved £1,139 per patient compared to LA (95% CI: -£1,255 to -£1,021; p<0.001), driven by fewer dialysis costs and infections. Interpretation: Both anaesthetic techniques are safe and efficacious. There was no clinical difference in fistula outcomes between the two groups. Regional anaesthesia proved cost-effective over a one-year time horizon when dialysis costs were excluded. Either technique continues to be appropriate for AVF creation.
- Open Access
- 2 September 2025
- Published by BMJ in Tobacco Control
Effect of comprehensive tobacco control policies on maternal and child outcomes: a population-based linkage study
Objectives: To assess the impact of comprehensive tobacco control policies on maternal smoking during pregnancy and perinatal outcomes over a 20-year period. Design: Population-based cohort study using linked Scottish National Health Service. We assessed the impact of tobacco control measures on maternal smoking and perinatal outcomes over four distinct time periods. Step and slope changes in risk were evaluated using multivariable Poisson regression models with robust errors to determine immediate and sustained effects. Setting: All Scottish National Health Service hospitals. Participants: 919 324 singleton births between 24+0 and 44+6 weeks gestation, spanning 1 January 2000 to 31 December 2019. Intervention: Tobacco control policies were introduced progressively over four periods. Period A (2000–2002) served as the reference. Period B (2002–2006) introduced advertising restrictions, including bans on tobacco sponsorship and product displays. Period C (2006–2016) incorporated smoke-free legislation, prohibiting smoking in enclosed public spaces. Period D (2016–2019) introduced further legislative measures, bans on smoking in vehicles carrying children and enhanced taxation policies. Main outcome measures: Maternal smoking, small for gestational age (SGA), stillbirth, preterm births and pre-eclampsia. Results: Comprehensive measures were associated with a reduction in maternal smoking (step change relative risk (RR)A to D 0.73 (95% CI 0.70 to 0.75), which was sustained over time (slope RRA to D 0.97 (95% CI 0.95 to 0.99)). There were also reductions in pre-eclampsia (slope RRA to D 0.88 (95% CI 0.80 to 0.96), SGA (slope RRA to D 0.94 (95% CI 0.90 to 0.97). While preterm births increased (primarily iatrogenic), and stillbirth rates declined, these trends were not directly attributable to tobacco control measures. Conclusion: Comprehensive tobacco control measures were associated with reduction in maternal smoking during pregnancy, pre-eclampsia and SGA, underscoring their potential to improve perinatal outcomes and supporting the global implementation of WHO-recommended tobacco-control strategies.
- 2 September 2025
- Published by BMJ in Tobacco Control
Open AccessEffect of comprehensive tobacco control policies on maternal and child outcomes: a population-based linkage study
Objectives: To assess the impact of comprehensive tobacco control policies on maternal smoking during pregnancy and perinatal outcomes over a 20-year period. Design: Population-based cohort study using linked Scottish National Health Service. We assessed the impact of tobacco control measures on maternal smoking and perinatal outcomes over four distinct time periods. Step and slope changes in risk were evaluated using multivariable Poisson regression models with robust errors to determine immediate and sustained effects. Setting: All Scottish National Health Service hospitals. Participants: 919 324 singleton births between 24+0 and 44+6 weeks gestation, spanning 1 January 2000 to 31 December 2019. Intervention: Tobacco control policies were introduced progressively over four periods. Period A (2000–2002) served as the reference. Period B (2002–2006) introduced advertising restrictions, including bans on tobacco sponsorship and product displays. Period C (2006–2016) incorporated smoke-free legislation, prohibiting smoking in enclosed public spaces. Period D (2016–2019) introduced further legislative measures, bans on smoking in vehicles carrying children and enhanced taxation policies. Main outcome measures: Maternal smoking, small for gestational age (SGA), stillbirth, preterm births and pre-eclampsia. Results: Comprehensive measures were associated with a reduction in maternal smoking (step change relative risk (RR)A to D 0.73 (95% CI 0.70 to 0.75), which was sustained over time (slope RRA to D 0.97 (95% CI 0.95 to 0.99)). There were also reductions in pre-eclampsia (slope RRA to D 0.88 (95% CI 0.80 to 0.96), SGA (slope RRA to D 0.94 (95% CI 0.90 to 0.97). While preterm births increased (primarily iatrogenic), and stillbirth rates declined, these trends were not directly attributable to tobacco control measures. Conclusion: Comprehensive tobacco control measures were associated with reduction in maternal smoking during pregnancy, pre-eclampsia and SGA, underscoring their potential to improve perinatal outcomes and supporting the global implementation of WHO-recommended tobacco-control strategies.
- Open Access
- 1 July 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (2) , e003264
Alcohol consumption during pregnancy in Scotland following public health interventions: population-based study
Introduction: Alcohol consumption during pregnancy is associated with adverse maternal and perinatal outcomes, with no safe lower limit established. We evaluated the individual and cumulative impact of three alcohol-related interventions on maternal alcohol use and perinatal outcomes in Scotland. Methods: Population-based study using Scottish National Health Service administrative linked data of all mothers giving birth in Scotland between 1 April 2013 and 31 December 2019. We investigated if alcohol consumption during pregnancy, as well as perinatal outcomes of small for gestational age (SGA), neonatal unit admission, and premature birth were affected by Public Health measures. The individual and cumulative effects of (1) Change in drink-driving legislation (5 December 2014), (2) UK Chief Medical Officers’ (CMO) advice to abstain from alcohol during pregnancy (6 January 2016) and (3) Alcohol minimum unit pricing (MUP) (1 May 2018) were assessed using time series analysis. Results: Of 346 360 antenatal care initiates, 92.7% had alcohol consumption data. By 2019, 26.1% reported alcohol use during pregnancy, with 55.2% women consuming >4 units per week. In women reporting alcohol use, MUP introduction showed a significant reduction in consumption by 0.59 (95% CI −0.99 to –0.18) units/week, contributing to an overall 0.69 (95% CI −0.90 to –0.48) units/week decrease following all interventions. Additionally, we observed improvements in perinatal outcomes, including reduced SGA (adjusted relative risk (adjRR) 0.88, 95% CI 0.85 to 0.90), and neonatal unit admission (adjRR 0.94, 95% CI 0.91 to 0.96), but not stillbirth (adjRR 0.87, 95% CI 0.74 to 1.02) or preterm birth (adjRR 1.09, 95% CI 1.06 to 1.13) following the implementation of these collective public health interventions. Conclusions: One in four women self-reported alcohol consumption during early pregnancy. Only MUP was associated with lower consumption among pregnant women. The public health measures were collectively associated with improvement in select perinatal outcomes, highlighting the potential effectiveness of universal interventions.
- 1 July 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (2) , e003264
Open AccessAlcohol consumption during pregnancy in Scotland following public health interventions: population-based study
Introduction: Alcohol consumption during pregnancy is associated with adverse maternal and perinatal outcomes, with no safe lower limit established. We evaluated the individual and cumulative impact of three alcohol-related interventions on maternal alcohol use and perinatal outcomes in Scotland. Methods: Population-based study using Scottish National Health Service administrative linked data of all mothers giving birth in Scotland between 1 April 2013 and 31 December 2019. We investigated if alcohol consumption during pregnancy, as well as perinatal outcomes of small for gestational age (SGA), neonatal unit admission, and premature birth were affected by Public Health measures. The individual and cumulative effects of (1) Change in drink-driving legislation (5 December 2014), (2) UK Chief Medical Officers’ (CMO) advice to abstain from alcohol during pregnancy (6 January 2016) and (3) Alcohol minimum unit pricing (MUP) (1 May 2018) were assessed using time series analysis. Results: Of 346 360 antenatal care initiates, 92.7% had alcohol consumption data. By 2019, 26.1% reported alcohol use during pregnancy, with 55.2% women consuming >4 units per week. In women reporting alcohol use, MUP introduction showed a significant reduction in consumption by 0.59 (95% CI −0.99 to –0.18) units/week, contributing to an overall 0.69 (95% CI −0.90 to –0.48) units/week decrease following all interventions. Additionally, we observed improvements in perinatal outcomes, including reduced SGA (adjusted relative risk (adjRR) 0.88, 95% CI 0.85 to 0.90), and neonatal unit admission (adjRR 0.94, 95% CI 0.91 to 0.96), but not stillbirth (adjRR 0.87, 95% CI 0.74 to 1.02) or preterm birth (adjRR 1.09, 95% CI 1.06 to 1.13) following the implementation of these collective public health interventions. Conclusions: One in four women self-reported alcohol consumption during early pregnancy. Only MUP was associated with lower consumption among pregnant women. The public health measures were collectively associated with improvement in select perinatal outcomes, highlighting the potential effectiveness of universal interventions.
- 21 May 2025
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 135 (1) , 9-13
Maternal fever, epidural analgesia, and genetics: implications for the neonate
- 21 May 2025
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 135 (1) , 9-13
Maternal fever, epidural analgesia, and genetics: implications for the neonate
- Open Access
- 8 January 2025
- Published by Wiley in Anaesthesia
- Vol. 80 (S2) , 115-124
Anaesthetic management of oncological disease in pregnancy: a narrative review
Summary: Introduction: Cancer complicates approximately 1 in 2000 pregnancies, with increasing incidence due to factors such as increased maternal age, obesity and advancements in antenatal testing. Anaesthetists play a crucial role in managing pregnant patients with cancer, both during delivery and in providing anaesthesia for oncological treatments. This review explores the challenges in anaesthetic management and specific considerations for common cancers encountered in pregnant patients. Methods: An electronic literature search was carried out using PubMed and Google Scholar to identify peer‐reviewed articles published in English from 1 January 1990 to 30 July 2024. Results: Two main areas were identified: anaesthetic management related to pregnancy and the peripartum period in patients with cancer; and oncological management during pregnancy. Current data suggest that pregnancy does not worsen cancer prognosis, but diagnosis and treatment are complicated by the overlap of cancer symptoms with physiological changes of pregnancy and concerns about the safety of diagnostic procedures and treatments. Ultrasound and magnetic resonance imaging are preferred imaging modalities, while careful use of ionising radiation is advised. Treatment during pregnancy, including surgery, chemotherapy and radiotherapy is possible, with specific timing and modality considerations to ensure maternal and fetal safety. Anaemia, poor nutrition and preterm birth are significant concerns in managing pregnant patients with cancer. For operative births, neuraxial techniques are preferred, though general anaesthesia may be required in complex cases. Comprehensive multidisciplinary support, including psychosocial care, is essential for optimal outcomes. Oncological surgery during pregnancy should preferably be scheduled for the second trimester, with consideration for fetal monitoring and steroids. Regional anaesthesia should be utilised if possible and uteroplacental perfusion maintained. Increased risks of thromboembolism should be addressed postoperatively, along with psychological support. Discussion: Effective and safe anaesthetic management of cancer in pregnancy requires a multidisciplinary approach to balance maternal and fetal safety, with a focus on careful planning and individualised care.
- 8 January 2025
- Published by Wiley in Anaesthesia
- Vol. 80 (S2) , 115-124
Open AccessAnaesthetic management of oncological disease in pregnancy: a narrative review
Summary: Introduction: Cancer complicates approximately 1 in 2000 pregnancies, with increasing incidence due to factors such as increased maternal age, obesity and advancements in antenatal testing. Anaesthetists play a crucial role in managing pregnant patients with cancer, both during delivery and in providing anaesthesia for oncological treatments. This review explores the challenges in anaesthetic management and specific considerations for common cancers encountered in pregnant patients. Methods: An electronic literature search was carried out using PubMed and Google Scholar to identify peer‐reviewed articles published in English from 1 January 1990 to 30 July 2024. Results: Two main areas were identified: anaesthetic management related to pregnancy and the peripartum period in patients with cancer; and oncological management during pregnancy. Current data suggest that pregnancy does not worsen cancer prognosis, but diagnosis and treatment are complicated by the overlap of cancer symptoms with physiological changes of pregnancy and concerns about the safety of diagnostic procedures and treatments. Ultrasound and magnetic resonance imaging are preferred imaging modalities, while careful use of ionising radiation is advised. Treatment during pregnancy, including surgery, chemotherapy and radiotherapy is possible, with specific timing and modality considerations to ensure maternal and fetal safety. Anaemia, poor nutrition and preterm birth are significant concerns in managing pregnant patients with cancer. For operative births, neuraxial techniques are preferred, though general anaesthesia may be required in complex cases. Comprehensive multidisciplinary support, including psychosocial care, is essential for optimal outcomes. Oncological surgery during pregnancy should preferably be scheduled for the second trimester, with consideration for fetal monitoring and steroids. Regional anaesthesia should be utilised if possible and uteroplacental perfusion maintained. Increased risks of thromboembolism should be addressed postoperatively, along with psychological support. Discussion: Effective and safe anaesthetic management of cancer in pregnancy requires a multidisciplinary approach to balance maternal and fetal safety, with a focus on careful planning and individualised care.
- 25 November 2024
- Published by Wiley in Anaesthesia
- Vol. 80 (2) , 170-178
Regional anaesthesia research priorities: a Regional Anaesthesia UK ( RA ‐ UK ) priority setting partnership involving patients, carers and healthcare professionals
Summary: Introduction: Regional anaesthesia provides important clinical benefits to patients but is underutilised. A barrier to widespread adoption may be the focus of regional anaesthesia research on novel techniques rather than evaluating and optimising existing approaches. Research priorities in regional anaesthesia identified by anaesthetists have been published, but the views of patients, carers and other healthcare professionals have not been considered previously. Therefore, we launched a multidisciplinary research priority setting partnership that aimed to establish key regional anaesthesia research priorities for the UK. Methods: Research suggestions from key stakeholders (defined by their interaction with regional anaesthesia) were gathered using an online survey. These suggestions were analysed to identify common themes and then combined to formulate indicative research questions. After an extensive literature review, unanswered and partially answered questions were prioritised via an interim online survey and then ranked as a top 10 list during a final live virtual multidisciplinary prioritisation workshop. Results: In total, 210 individuals completed the initial survey and suggested 518 research questions. Fifty‐seven indicative questions were formed, of which three were considered fully answered after literature review and one not feasible. The interim online survey received 335 responses, which identified the 24 highest priority questions from the 53 presented. At the final live prioritisation workshop, through a nominal group process, we identified the top 10 regional anaesthesia research priorities. These aligned with three broad thematic areas: pain management (two questions); patient safety (six questions); and recovery from surgery (two questions). Discussion: This initiative has resulted in a list of research questions prioritised by patients, carers and a multidisciplinary group of healthcare professionals that should be used to inform and support future regional anaesthesia research in the UK.
- 25 November 2024
- Published by Wiley in Anaesthesia
- Vol. 80 (2) , 170-178
Regional anaesthesia research priorities: a Regional Anaesthesia UK ( RA ‐ UK ) priority setting partnership involving patients, carers and healthcare professionals
Summary: Introduction: Regional anaesthesia provides important clinical benefits to patients but is underutilised. A barrier to widespread adoption may be the focus of regional anaesthesia research on novel techniques rather than evaluating and optimising existing approaches. Research priorities in regional anaesthesia identified by anaesthetists have been published, but the views of patients, carers and other healthcare professionals have not been considered previously. Therefore, we launched a multidisciplinary research priority setting partnership that aimed to establish key regional anaesthesia research priorities for the UK. Methods: Research suggestions from key stakeholders (defined by their interaction with regional anaesthesia) were gathered using an online survey. These suggestions were analysed to identify common themes and then combined to formulate indicative research questions. After an extensive literature review, unanswered and partially answered questions were prioritised via an interim online survey and then ranked as a top 10 list during a final live virtual multidisciplinary prioritisation workshop. Results: In total, 210 individuals completed the initial survey and suggested 518 research questions. Fifty‐seven indicative questions were formed, of which three were considered fully answered after literature review and one not feasible. The interim online survey received 335 responses, which identified the 24 highest priority questions from the 53 presented. At the final live prioritisation workshop, through a nominal group process, we identified the top 10 regional anaesthesia research priorities. These aligned with three broad thematic areas: pain management (two questions); patient safety (six questions); and recovery from surgery (two questions). Discussion: This initiative has resulted in a list of research questions prioritised by patients, carers and a multidisciplinary group of healthcare professionals that should be used to inform and support future regional anaesthesia research in the UK.
- 13 June 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 133 (2) , 247-254
Epidural analgesia in labour: separating fact from fiction for autism and neurodevelopment
- 13 June 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 133 (2) , 247-254
Epidural analgesia in labour: separating fact from fiction for autism and neurodevelopment
- Top Cited PapersOpen Access
Epidural analgesia during labour and severe maternal morbidity: population based study
Objectives To determine the effect of labour epidural on severe maternal morbidity (SMM) and to explore whether this effect might be greater in women with a medical indication for epidural analgesia during labour, or with preterm labour. Design Population based study. Setting All NHS hospitals in Scotland. Participants 567 216 women in labour at 24+0 to 42+6 weeks’ gestation between 1 January 2007 and 31 December 2019, delivering vaginally or through unplanned caesarean section. Main outcome measures The primary outcome was SMM, defined as the presence of ≥1 of 21 conditions used by the US Centers for Disease Control and Prevention (CDC) as criteria for SMM, or a critical care admission, with either occurring at any point from date of delivery to 42 days post partum (described as SMM). Secondary outcomes included a composite of ≥1 of the 21 CDC conditions and critical care admission (SMM plus critical care admission), and respiratory morbidity. Results Of the 567 216 women, 125 024 (22.0%) had epidural analgesia during labour. SMM occurred in 2412 women (4.3 per 1000 births, 95% confidence interval (CI) 4.1 to 4.4). Epidural analgesia was associated with a reduction in SMM (adjusted relative risk 0.65, 95% CI 0.50 to 0.85), SMM plus critical care admission (0.46, 0.29 to 0.73), and respiratory morbidity (0.42, 0.16 to 1.15), although the last of these was underpowered and had wide confidence intervals. Greater risk reductions in SMM were detected among women with a medical indication for epidural analgesia (0.50, 0.34 to 0.72) compared with those with no such indication (0.67, 0.43 to 1.03; PConclusion Epidural analgesia during labour was associated with a 35% reduction in SMM, and showed a more pronounced effect in women with medical indications for epidural analgesia and with preterm births. Expanding access to epidural analgesia for all women during labour, and particularly for those at greatest risk, could improve maternal health.
Top Cited PapersOpen AccessEpidural analgesia during labour and severe maternal morbidity: population based study
Objectives To determine the effect of labour epidural on severe maternal morbidity (SMM) and to explore whether this effect might be greater in women with a medical indication for epidural analgesia during labour, or with preterm labour. Design Population based study. Setting All NHS hospitals in Scotland. Participants 567 216 women in labour at 24+0 to 42+6 weeks’ gestation between 1 January 2007 and 31 December 2019, delivering vaginally or through unplanned caesarean section. Main outcome measures The primary outcome was SMM, defined as the presence of ≥1 of 21 conditions used by the US Centers for Disease Control and Prevention (CDC) as criteria for SMM, or a critical care admission, with either occurring at any point from date of delivery to 42 days post partum (described as SMM). Secondary outcomes included a composite of ≥1 of the 21 CDC conditions and critical care admission (SMM plus critical care admission), and respiratory morbidity. Results Of the 567 216 women, 125 024 (22.0%) had epidural analgesia during labour. SMM occurred in 2412 women (4.3 per 1000 births, 95% confidence interval (CI) 4.1 to 4.4). Epidural analgesia was associated with a reduction in SMM (adjusted relative risk 0.65, 95% CI 0.50 to 0.85), SMM plus critical care admission (0.46, 0.29 to 0.73), and respiratory morbidity (0.42, 0.16 to 1.15), although the last of these was underpowered and had wide confidence intervals. Greater risk reductions in SMM were detected among women with a medical indication for epidural analgesia (0.50, 0.34 to 0.72) compared with those with no such indication (0.67, 0.43 to 1.03; PConclusion Epidural analgesia during labour was associated with a 35% reduction in SMM, and showed a more pronounced effect in women with medical indications for epidural analgesia and with preterm births. Expanding access to epidural analgesia for all women during labour, and particularly for those at greatest risk, could improve maternal health.